2019 Q1 Form 10-K Financial Statement
#000121380919000006 Filed on March 27, 2019
Income Statement
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
Revenue | $402.5K | $1.295M | $160.0K |
YoY Change | 118.37% | 70.81% | -67.35% |
Cost Of Revenue | $327.9K | $1.027M | $140.0K |
YoY Change | 123.35% | 51.03% | -66.67% |
Gross Profit | $74.62K | $268.2K | $20.00K |
YoY Change | 98.89% | 242.83% | -71.43% |
Gross Profit Margin | 18.54% | 20.7% | 12.5% |
Selling, General & Admin | $1.430M | $4.520M | $880.0K |
YoY Change | 10.85% | -10.14% | -46.34% |
% of Gross Profit | 1916.27% | 1685.48% | 4400.0% |
Research & Development | $692.4K | $2.102M | $670.0K |
YoY Change | 20.02% | 19.04% | |
% of Gross Profit | 927.81% | 783.68% | 3350.0% |
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $692.4K | $2.102M | $1.550M |
YoY Change | 20.02% | 19.04% | -22.11% |
Operating Profit | -$2.441M | -$7.592M | -$1.530M |
YoY Change | 9.49% | 6.53% | -20.31% |
Interest Expense | $267.0K | $894.5K | $180.0K |
YoY Change | 43.18% | 58.0% | -300.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $894.5K | ||
YoY Change | -81.83% | ||
Pretax Income | -$2.170M | -$6.623M | -$1.360M |
YoY Change | 6.37% | 215.83% | -32.34% |
Income Tax | $900.00 | -$1.006M | -$790.0K |
% Of Pretax Income | |||
Net Earnings | -$2.175M | -$5.692M | -$1.370M |
YoY Change | 6.46% | 166.49% | -33.5% |
Net Earnings / Revenue | -540.4% | -439.36% | -856.25% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$81.62K | -$205.6K | -$47.82K |
COMMON SHARES | |||
Basic Shares Outstanding | 26.71M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $39.75M | $41.20M | $47.69M |
YoY Change | -15.05% | -13.61% | -2.55% |
Cash & Equivalents | $3.976M | $2.390M | $5.786M |
Short-Term Investments | $35.78M | $38.82M | $41.90M |
Other Short-Term Assets | $290.0K | $430.0K | $1.170M |
YoY Change | -62.82% | -63.25% | -84.61% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $426.0K | $320.0K | $271.0K |
Other Receivables | $830.0K | $800.0K | $490.0K |
Total Short-Term Assets | $41.31M | $42.75M | $49.62M |
YoY Change | -14.19% | -13.85% | -13.91% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | $920.0K | |
YoY Change | -100.0% | -14.02% | |
Other Assets | $50.95K | $50.00K | $53.49K |
YoY Change | -71.69% | -76.19% | 434.92% |
Total Long-Term Assets | $551.6K | $550.0K | $1.128M |
YoY Change | -18.89% | -50.89% | 5.46% |
TOTAL ASSETS | |||
Total Short-Term Assets | $41.31M | $42.75M | $49.62M |
Total Long-Term Assets | $551.6K | $550.0K | $1.128M |
Total Assets | $41.86M | $43.30M | $50.74M |
YoY Change | -14.26% | -14.66% | -13.55% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $948.1K | $310.0K | $520.3K |
YoY Change | 101.71% | -40.38% | 85.81% |
Accrued Expenses | $303.0K | $400.0K | $148.0K |
YoY Change | -15.84% | 166.67% | -62.06% |
Deferred Revenue | $23.02K | $0.00 | |
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.274M | $850.0K | $768.9K |
YoY Change | 27.41% | 10.39% | -23.87% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.274M | $850.0K | $768.9K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $1.270M | $850.0K | $770.0K |
YoY Change | 27.0% | 10.39% | -23.76% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$35.22M | -$27.35M | |
YoY Change | |||
Common Stock | $38.97K | $38.94K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $18.90M | $16.60M | |
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $40.59M | $42.45M | $49.98M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $41.86M | $43.30M | $50.74M |
YoY Change | -14.26% | -14.66% | -13.55% |
Cashflow Statement
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.175M | -$5.692M | -$1.370M |
YoY Change | 6.46% | 166.49% | -33.5% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$1.410M | -$4.407M | -$1.160M |
YoY Change | 113.32% | 160.6% | -22.67% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $3.010M | $3.330M | $1.880M |
YoY Change | -2608.33% | -511.11% | -69.38% |
Cash From Investing Activities | $3.006M | $3.328M | $1.880M |
YoY Change | -2544.04% | -509.85% | -69.38% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | $2.304M | |
YoY Change | -100.0% | -62.98% | |
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $0.00 | -$2.300M | -530.0K |
YoY Change | -100.0% | -63.04% | -85.24% |
NET CHANGE | |||
Cash From Operating Activities | -$1.410M | -$4.407M | -1.160M |
Cash From Investing Activities | $3.006M | $3.328M | 1.880M |
Cash From Financing Activities | $0.00 | -$2.300M | -530.0K |
Net Change In Cash | $1.589M | -$3.400M | 190.0K |
YoY Change | -237.61% | -59.85% | -81.9% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.410M | -$4.407M | -$1.160M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
CY2018 | dei |
Document Type
DocumentType
|
10-K | |
CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001213809 | |
CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
26713486 | shares |
CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
29800000 | USD |
CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
DYADIC INTERNATIONAL INC | |
CY2018 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2018Q4 | dyai |
Prepaid Researchand Developmentin Process Noncurrent
PrepaidResearchandDevelopmentinProcessNoncurrent
|
0 | USD |
CY2017Q4 | dyai |
Prepaid Researchand Development
PrepaidResearchandDevelopment
|
1200000 | USD |
CY2018Q4 | dyai |
Prepaid Researchand Development
PrepaidResearchandDevelopment
|
300000 | USD |
CY2017Q4 | dyai |
Prepaid Researchand Developmentin Process Current
PrepaidResearchandDevelopmentinProcessCurrent
|
1015194 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
520261 | USD |
CY2018Q4 | dyai |
Prepaid Researchand Developmentin Process Current
PrepaidResearchandDevelopmentinProcessCurrent
|
253446 | USD |
CY2017Q4 | dyai |
Prepaid Researchand Developmentin Process Noncurrent
PrepaidResearchandDevelopmentinProcessNoncurrent
|
152245 | USD |
CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2017 | dyai |
Provisionfor Contract Losses
ProvisionforContractLosses
|
220715 | USD |
CY2018 | dyai |
Provisionfor Contract Losses
ProvisionforContractLosses
|
0 | USD |
CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2017Q4 | dyai |
Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
|
60188 | USD |
CY2018Q4 | dyai |
Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
|
49666 | USD |
CY2017 | dyai |
Adjustment For Provisions Of Contract Losses
AdjustmentForProvisionsOfContractLosses
|
-216324 | USD |
CY2018 | dyai |
Adjustment For Provisions Of Contract Losses
AdjustmentForProvisionsOfContractLosses
|
0 | USD |
CY2017Q2 | dyai |
Collaborative Arrangement Duration Of Agreement
CollaborativeArrangementDurationOfAgreement
|
P2Y | |
CY2017Q2 | dyai |
Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
|
1000000 | EUR |
CY2017Q2 | dyai |
Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
|
1100000 | USD |
CY2017Q4 | dyai |
Deferred Tax Asset Liability Gross
DeferredTaxAssetLiabilityGross
|
3891700 | USD |
CY2018Q4 | dyai |
Deferred Tax Asset Liability Gross
DeferredTaxAssetLiabilityGross
|
4578400 | USD |
CY2017Q4 | dyai |
Deferred Tax Liabilities Parents Basisin Disposal Group
DeferredTaxLiabilitiesParentsBasisinDisposalGroup
|
5900 | USD |
CY2018Q4 | dyai |
Deferred Tax Liabilities Parents Basisin Disposal Group
DeferredTaxLiabilitiesParentsBasisinDisposalGroup
|
0 | USD |
CY2017 | dyai |
Effective Income Tax Rate Reconciliation Alternative Minimum Tax Percent
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent
|
0.0000 | |
CY2018 | dyai |
Effective Income Tax Rate Reconciliation Alternative Minimum Tax Percent
EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxPercent
|
-0.0006 | |
CY2017 | dyai |
Effective Income Tax Rate Reconciliation True Up Adjustment Percent
EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent
|
-0.0710 | |
CY2018 | dyai |
Effective Income Tax Rate Reconciliation True Up Adjustment Percent
EffectiveIncomeTaxRateReconciliationTrueUpAdjustmentPercent
|
0.0017 | |
CY2017 | dyai |
Income Tax Expense Benefit Including True Up Adjustment
IncomeTaxExpenseBenefitIncludingTrueUpAdjustment
|
-66694 | USD |
CY2018 | dyai |
Income Tax Expense Benefit Including True Up Adjustment
IncomeTaxExpenseBenefitIncludingTrueUpAdjustment
|
-1001233 | USD |
CY2017 | dyai |
Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
|
1167439 | USD |
CY2018 | dyai |
Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
|
-913013 | USD |
CY2017Q4 | dyai |
Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
|
48607750 | USD |
CY2018Q4 | dyai |
Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
|
41202755 | USD |
CY2017 | dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
437621 | USD |
CY2018 | dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
1215536 | USD |
CY2017 | dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
104342 | USD |
CY2018 | dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
87363 | USD |
CY2017 | dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
2203095 | USD |
CY2018 | dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
3317164 | USD |
CY2017 | dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
1299072 | USD |
CY2018 | dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
1637953 | USD |
CY2017 | dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
362060 | USD |
CY2018 | dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
376312 | USD |
CY2017Q4 | dyai |
Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
|
459141 | USD |
CY2018Q4 | dyai |
Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
|
240064 | USD |
CY2017 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
437621 | USD |
CY2018 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
1215536 | USD |
CY2018 | dyai |
Tax Cutsand Jobs Act Change In Alternative Minimum Tax Income Tax Benefit
TaxCutsandJobsActChangeInAlternativeMinimumTaxIncomeTaxBenefit
|
1001233 | USD |
CY2017Q4 | dyai |
Tax Cutsand Jobs Act Changein Tax Rate Deferred Tax Asset Income Tax Expense
TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense
|
400000 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
309060 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
54255 | USD |
CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14254216 | USD |
CY2017Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
98431 | USD |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
85321 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
68996 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5786348 | USD |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
271029 | USD |
CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
318744 | USD |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
147959 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2386314 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
5786348 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
2386314 | USD |
CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2712390 | shares |
CY2018 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3552890 | shares |
CY2017Q4 | us-gaap |
Assets
Assets
|
50744159 | USD |
CY2018Q4 | us-gaap |
Assets
Assets
|
43300807 | USD |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
49615774 | USD |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
42748052 | USD |
CY2017Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | USD |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | USD |
CY2018Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
399576 | USD |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
6865 | USD |
CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
0 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
93913557 | USD |
CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
94385230 | USD |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
643430 | USD |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
467203 | USD |
CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
643430 | USD |
CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
467203 | USD |
CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5786348 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2386314 | USD |
CY2017 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-8467868 | USD |
CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3400034 | USD |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
38936988 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
38966988 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
28327811 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
26713486 | shares |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
38937 | USD |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
38967 | USD |
CY2017Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
0 | USD |
CY2018Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
141002 | USD |
CY2017 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
680197 | USD |
CY2018 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1027278 | USD |
CY2017 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
7885302 | USD |
CY2018 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8887896 | USD |
CY2017Q1 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1088000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
2668000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
11200 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
1005300 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1656500 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
1656500 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
154300 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
242700 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3891700 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4578400 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
6500 | USD |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | |
CY2017 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
257920 | USD |
CY2018 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-21622 | USD |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0441 | |
CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.1495 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3400 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.1297 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.1025 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.1940 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0000 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.0066 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.0028 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.0173 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.0044 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0345 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0425 | |
CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
83674 | USD |
CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
268287 | USD |
CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
211012 | USD |
CY2018Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
162786 | USD |
CY2017 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
-66694 | USD |
CY2018 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
-1001233 | USD |
CY2017 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
249059 | USD |
CY2018 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-20778 | USD |
CY2017 | us-gaap |
Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
|
0 | USD |
CY2018 | us-gaap |
Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
|
0 | USD |
CY2017 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
4358223 | USD |
CY2018 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | USD |
CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5030354 | USD |
CY2018 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4522676 | USD |
CY2017Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
41898754 | USD |
CY2018Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
38816441 | USD |
CY2017Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
922648 | USD |
CY2018Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
0 | USD |
CY2017 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-2202513 | USD |
CY2018 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-6697913 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-2096939 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6622695 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-105574 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-75218 | USD |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-66694 | USD |
CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1006157 | USD |
CY2017Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
0 | USD |
CY2018Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
506866 | USD |
CY2017Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
0 | USD |
CY2018Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
500616 | USD |
CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
207434 | USD |
CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-195755 | USD |
CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-333020 | USD |
CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
59984 | USD |
CY2017 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
97041 | USD |
CY2018 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-100675 | USD |
CY2017 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-3313 | USD |
CY2018 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-195601 | USD |
CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-242200 | USD |
CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
251617 | USD |
CY2017 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-122222 | USD |
CY2018 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
141002 | USD |
CY2017 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
0 | USD |
CY2018 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
1007482 | USD |
CY2017 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
47452 | USD |
CY2018 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-97726 | USD |
CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
17395 | USD |
CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
566146 | USD |
CY2018 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
894532 | USD |
CY2017Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
489841 | USD |
CY2018Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
294240 | USD |
CY2017 | us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
1107377 | USD |
CY2018 | us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
676644 | USD |
CY2017Q4 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
48509319 | USD |
CY2018Q4 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
41117434 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
50744159 | USD |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
43300807 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
768895 | USD |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
849638 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-6222530 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2299542 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-812084 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
3328319 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1691174 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4407189 | USD |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2135819 | USD |
CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5691756 | USD |
CY2017 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4924369 | USD |
CY2018 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
894532 | USD |
CY2018 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7126882 | USD |
CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7592445 | USD |
CY2017Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
2900000 | USD |
CY2018Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9100000 | USD |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4097 | USD |
CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
81623 | USD |
CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
53492 | USD |
CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
52139 | USD |
CY2017Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
63678 | USD |
CY2018Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
77249 | USD |
CY2017 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
6223967 | USD |
CY2018 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
2304042 | USD |
CY2017 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
51463084 | USD |
CY2018 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
49734681 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
154608 | USD |
CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
172001 | USD |
CY2017Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
89760 | USD |
CY2018Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
91725 | USD |
CY2017Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
1170 | USD |
CY2018Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
3027 | USD |
CY2017 | us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
163735 | USD |
CY2018 | us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
0 | USD |
CY2017 | us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
50651000 | USD |
CY2018 | us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
53063000 | USD |
CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1437 | USD |
CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4500 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
2082183 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
|
0 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
|
0 | USD |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1149461 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2158083 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2712390 | shares |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3552890 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.60 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.62 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.57 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.23 | |
CY2018Q4 | us-gaap |
Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
|
0 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
|
2082183 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
|
0 | USD |
CY2018Q4 | us-gaap |
Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
|
0 | USD |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1765474 | USD |
CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2101628 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-27351357 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-33043113 | USD |
CY2017 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
758420 | USD |
CY2018 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1295451 | USD |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
643430 | USD |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
467203 | USD |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2135598 | shares |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.57 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
7313 | USD |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
39360 | USD |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
100000 | shares |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
0 | shares |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
250000 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
660557 | shares |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1120500 | shares |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.82 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.41 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
214883 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
69090 | USD |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.23 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.15 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1.33 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0.00 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.00 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.69 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.61 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.44 | |
CY2018Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1149461 | USD |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y9M25D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M2D | |
CY2018Q3 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.40 | |
us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.52 | ||
CY2016 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.59 | |
CY2017Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
10609177 | shares |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y0M22D | |
CY2017 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
0 | USD |
CY2018 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
0 | USD |
CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6250 | shares |
CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6250 | shares |
CY2018 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
30000 | shares |
CY2017 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1437 | USD |
CY2018 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
4500 | USD |
CY2016Q1 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
15000000 | USD |
CY2017Q3 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
5000000 | USD |
CY2016Q1 | us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P1Y | |
CY2017Q3 | us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P1Y | |
CY2016Q4 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
4598094 | USD |
CY2017Q4 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
4462339 | USD |
CY2018Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
4087519 | USD |
CY2016Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
15000000 | USD |
CY2017Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
3214073 | USD |
CY2017Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
2551717 | USD |
CY2017Q3 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
5000000 | USD |
CY2018Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
4231339 | USD |
CY2018Q3 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
2158297 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
57690183 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49975264 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
42451169 | USD |
CY2017Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
100675 | USD |
CY2018Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
0 | USD |
CY2016Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.35 | |
CY2017Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.48 | |
CY2017Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.60 | |
CY2017Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.54 | |
us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.41 | ||
CY2018Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.40 | |
CY2018Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
1.41 | |
CY2018Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
12253502 | shares |
CY2016Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
2136752 | shares |
CY2017Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
448000 | shares |
CY2017Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
867507 | shares |
CY2017Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
2363590 | shares |
us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
381607 | shares | |
CY2018Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
165000 | shares |
CY2018Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
102000 | shares |
CY2018Q3 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
1377325 | shares |
us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
14390254 | shares | |
CY2016 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
6548473 | shares |
CY2017Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
16625873 | USD |
CY2017Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
16600000 | USD |
CY2018Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18900000 | USD |
CY2018Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18929915 | USD |
CY2016Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
2884615 | USD |
CY2017Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
662356 | USD |
CY2017Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
1384021 | USD |
CY2017Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
3639929 | USD |
us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
537661 | USD | |
CY2018Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
231000 | USD |
CY2018Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
143820 | USD |
CY2018Q3 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
1929222 | USD |
us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
21814530 | USD | |
CY2016 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
10401906 | USD |
CY2017 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
6223967 | USD |
CY2018 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
2304042 | USD |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
28917961 | shares |
CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
27673300 | shares |
CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, and investment securities. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts. </font></div></div> | |
CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;">The preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.</font></div></div> |